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An electrophilic iodocyclization reaction involving alkynylated 2-iodoanisoles and molecular 
iodine in the presence of sodium bicarbonate was developed and diiodo-functionalized benzo[b]furans  
were obtained in yields from 45 to 99%.
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Introduction
Heterocyclic aromatic compounds constitute a 
class of substances with a considerable diversity of 
pharmacological properties.1 Accordingly, natural and 
synthetic heteroaromatic compounds have been employed 
as drugs.2 Focusing on benzo[b]furans (1), we came 
across an important subclass of heterocyclic aromatic 
compounds, which comprises various biological activities, 
such as anticancer,3-6 antiviral,7-9 anti-inflammatory,10-12 
and immunosuppressive.13,14 In this sense, we present 
the structures of the benzo[b]furans obovaten (2), a 
natural product with pronounced antitumor activity,15,16 
and amiodarone (3), a commercial antiarrhythmic drug17 
(Figure 1).
A number of approaches have been developed towards the 
efficient construction of benzo[b]furan scaffolds.18-26 Among 
them we highlight the metal-catalyzed cross-coupling/
cyclization reactions18-22 and the electrophilic cyclization 
reactions employing alkynylanisoles.23-26 The latter 
approach can be illustrated by the iodocyclization reaction 
developed by Larock and co-workers.26 Nevertheless, 
in the course of our research activities aiming to the 
synthesis of diiodo-functionalized compounds,27-29 for 
application in selective cross-coupling reactions,30,31 we 
observed that diiodo-functionalized benzo[b]furans could 
not be achieved through the reaction between alkynylated 
2-iodoanysoles and molecular iodine, using the Larock’s 
conditions for the preparation of iodinated benzo[b]furans.26 
In this context, we focused on development of a novel 
methodology to obtain diiodo-functionalized benzo[b]furans 
via electrophilic iodocyclization reaction, employing 
alkynylated 2-iodoanysoles and molecular iodine.
Results and Discussion
Initially, the reaction between the alkynylated 
2-iodoanysole 4a and 2 equiv. of iodine in dichloromethane 
at room temperature for 3 h provided the diiodo-
functionalized benzo[b]furan 5a in a yield lower than 5% 
(Table 1, entry 1). In an attempt to improve the yield, we 
performed the reaction between compound 4a and 2 equiv. 
of iodine in dichloromethane at room temperature for 12 h 
and obtained the desired product 5a in 34% yield (entry 2). 
When the same transformation was carried out at 40 °C, 
the diiodo-functionalized benzo[b]furan 5a was isolated 
in 44% yield (entry 3).
Allowing the reaction between the alkynylated 
2-iodoanysole 4a, 2 equiv. of iodine, and 2 equiv. of 
NaHCO3 in dichloromethane at 40 °C for 12 h, we 
obtained the diiodo-functionalized benzo[b]furan 5a in 
65% yield (Table 1, entry 4). By employing other bases, 
namely 2 equiv. of K2CO3 and 2 equiv. of n-Bu4NI, the 
heteroaromatic compound 5a was obtained in yields of 
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Figure 1. Structures of benzo[b]furan compounds.
Table 1. Preparation of diiodo-functionalized benzo[b]furan (5a)a
 
entry I2 (equiv.) Base (equiv.) Solvent Temperature / °C time / h Isolated yield / %
1 2 - CH2Cl2 r.t. 3 < 5
2 2 - CH2Cl2 r.t. 12 34
3 2 - CH2Cl2 40 12 44
4 2 NaHCO3 (2) CH2Cl2 40 12 65
5 2 K2CO3 (2) CH2Cl2 40 12 51
6 2 n-Bu4NI (2) CH2Cl2 40 12 63
7 2 NaHCO3 (2) ClCH2CH2Cl 70 12 82
8 2 NaHCO3 (3) ClCH2CH2Cl 70 12 85
9 2 NaHCO3 (3) ClCH2CH2Cl 70 24 89
10 3 NaHCO3 (3) ClCH2CH2Cl 70 12 87
11 3 NaHCO3 (3) ClCH2CH2Cl 70 24 97
aReaction conditions: 0.25 mmol of compound 4a, the indicated amount of I2, the indicated amount of base, and 5 mL of solvent were maintained under 
stirring at the temperature shown for the indicated time.
51 and 63%, respectively (entries 5 and 6). In order to 
increase the reaction temperature, we decided to evaluate 
another solvent. Thus, we carried out the reaction between 
the alkynylated 2-iodoanysole 4a, 2 equiv. of iodine, and 
2 equiv. of NaHCO3 in 1,2-dichloroethane at 70 °C for 12 h 
and obtained the diiodo-functionalized benzo[b]furan 5a 
in 82% yield (entry 7). By using 3 equiv. of NaHCO3, 
compound 5a was isolated in 85% yield (entry 8). 
When the alkynylated 2-iodoanysole 4a was allowed to 
react with 2 equiv. of iodine and 3 equiv. of NaHCO3 
in 1,2-dichloroethane at 70 °C for 24 h, the diiodo-
functionalized benzo[b]furan 5a was obtained in 89% yield 
(entry 9). By using 3 equiv. of iodine for 12 h, compound 
5a was isolated in 87% (entry 10). Ultimately, the reaction 
between the alkynylated 2-iodoanysole 4a, 3 equiv. of 
iodine, and 3 equiv. of NaHCO3 in 1,2-dichloroethane at 
70 °C for 24 h provided the heteroaromatic compound 5a 
in 97% isolated yield (entry 11).
Employing the optimal conditions (Table 1, entry 11), 
we examined the scope of the transformation using 
alkynylated 2-iodoanysoles 4 with electron-donating 
and -withdrawing groups attached to the aromatic ring as 
well as alkyl and aryl groups bonded to the triple bond 
(Table 2).
Allowing compounds 4a and 4b to react with 3 equiv. 
of iodine and 3 equiv. of NaHCO3 in 1,2-dichloroethane 
at 70 °C for 24 h, we obtained the desired products 5a 
and 5b in 97 and 71% yields, respectively (Table 2, 
entries 1 and 2). The reactions between chloro-containing 
compounds 4c and 4d were more sluggish than the 
transformations presented in entries 1 and 2 and the 
chloro-containing heteroaromatic compounds 5c and 
5d were isolated in 57 and 46% yields, respectively 
(entries 3 and 4). When compounds 4c and 4d were allowed 
to react for 48 h, the desired products 5c and 5d were 
obtained in 92 and 52% yields, respectively (Table 2, 
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Table 2. Diiodo-functionalized benzo[b]furans (5a-i) prepared by the electrophilic iodocyclization reactiona
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entries 3 and 4). Reactions with methyl-containing 
compounds 4e and 4f in the presence of 3 equiv. of iodine 
and 3 equiv. of NaHCO3 in 1,2-dichloroethane at 70 °C 
for 24 h gave the methyl-containing heteroaromatic 
compounds 5e and 5f in isolated yields of 99 and 75%, 
respectively (entries 5 and 6). When the alkynylated 
2-iodoanysole 4g bearing an electron-rich aromatic ring 
bonded to the triple bond was subjected to the reaction, the 
heteroaromatic compound 5g was obtained in 99% yield 
(entry 7). We did not try to perform the iodocyclization 
of an alkynylated 2-iodoanysole bearing an electron-poor 
aromatic ring bonded to the triple bond. In addition, 
when the alkynylated 2-iodoanysole 4h bearing an alkyl 
group attached to the triple bond was allowed to react, the 
heteroaromatic compound 5h was isolated in 69% yield 
(entry 8). Treatment of the chloro-containing alkynylated 
2-iodoanysole 4i having an alkyl group bonded to the 
triple bond with 3 equiv. of iodine and 3 equiv. of NaHCO3 
in 1,2-dichloroethane at 70 °C for 24 h afforded the 
desired product 5i in a moderate yield of 45% (entry 9). 
Alkynylated anisoles bearing an alkyl group attached to 
the triple bond fail to undergo electrophilic cyclizations 
employing the protocol published by Larock and co-
workers.26 However, using our protocol the alkynylated 
2-iodoanysoles bearing an alkyl group (4b, 4d, 4f, 4h, 
and 4i) provided diiodo-functionalized benzo[b]furan (5b, 
5d, 5f, 5h, and 5i) in reasonable yields (Table 2, entries 
2, 4, 6, 8, and 9).
Presumably, the iodocyclization reported proceed 
through the formation of the iodonium ion A, followed 
by a five endo-dig cyclization leading to the oxonium 
ion B, which undergoes methyl group removal via SN2 
displacement by a nucleophile present in the reaction 
mixture23-26 (Scheme 1).
The structures of compounds 5a-i were assigned 
according to their 1H nuclear magnetic resonance (NMR), 
13C NMR, infrared (IR), and mass spectra. All new 
compounds (5b-i) provided high-resolution mass spectra 
(HRMS) that are in agreement with the proposed structures.
Conclusions
In summary, an electrophilic iodocyclization reaction 
involving alkynylated 2-iodoanisoles and molecular iodine 
in the presence of sodium bicarbonate was developed 
and diiodo-functionalized benzo[b]furans were obtained 
in yields from 45 to 99%. Our transformation provided 
benzo[b]furans even when alkynylated 2-iodoanisoles 
bearing alkyl groups attached to the triple bond were 
employed. The iodocyclization reported can be considered 
a convenient approach to prepare diiodo-functionalized 
benzo[b]furans and should find use in the construction 









aReaction conditions: 0.25 mmol of compound 4a-i, 0.75 mmol of I2, 0.75 mmol of NaHCO3, and 5 mL of ClCH2CH2Cl were maintained under stirring 
at 70 °C for 24 h; bthis yield was obtained after 48 h of reaction.
Table 2. Diiodo-functionalized benzo[b]furans (5a-i) prepared by the electrophilic iodocyclization reactiona (cont.)
Scheme 1. Proposed mechanism for the electrophilic iodocyclization 
developed.
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of molecules with interesting biological properties and 
applications in materials science.
Experimental
General methods
1H and 13C NMR spectra were recorded on spectrometer 
operating at 200 and 50 MHz, respectively. 1H NMR spectra 
were taken in CDCl3, and the chemical shifts were given 
in ppm with respect to tetramethylsilane (TMS) used as an 
internal standard. 13C NMR spectra were taken in CDCl3, 
and the chemical shifts were given in ppm with respect 
to the deuterated solvent used as a reference. Infrared 
spectra were obtained using attenuated total reflectance 
(ATR) technique or KBr pellets in the 4000-400 cm−1 
region. Mass spectra were carried out employing a gas 
chromatograph connected to a mass spectrometer using 
electron impact ionization (EI) at 70 eV. High resolution 
mass spectra were obtained using a time-of-flight (TOF) 
mass spectrometer. Melting point values are uncorrected. 
Column chromatography separations were carried out 
using 70-230 mesh silica gel. Commercially obtained 
reagents and solvents were employed without purification. 
Alkynylated 2-iodoanysoles (4a-i) were prepared according 
to the literature.31
General procedure for the preparation of diiodo-functionalized 
benzo[b]furans (5a-i)
To a vial (20 mL) were added the alkynylated 
2-iodoanysole 4 (0.25 mmol), NaHCO3 (63 mg, 0.75 mmol), 
and a solution of iodine (190 mg, 0.75 mmol) in 
1,2-dichloroethane (5 mL). The vial was sealed using a 
cap, and the mixture was stirred at 70 °C for 24 hours. 
Afterwards, a saturated solution of sodium thiosulfate 
(10 mL) was added to the reaction, which was extracted 
with ethyl acetate (3 × 10 mL). The organic phase was dried 
over MgSO4. After filtration, the solvent was evaporated 
under reduced pressure. The residue was purified by column 
chromatography on silica gel using hexane as eluent, 
affording the diiodo-functionalized benzo[b]furan 5.
3,7-Diiodo-2-phenylbenzofuran (5a)
Yie ld :  108  mg  (97%) ; 
off-white solid; m.p. 110-112 °C 
(lit.31 m.p. 110-112 °C); 1H NMR 
(200 MHz, CDCl3) d 8.23-8.18 
(m, 2H), 7.70 (dd, 1H, J 7.7, 
1.1 Hz), 7.55-7.37 (m, 4H), 7.06 
(t, 1H, J 7.7 Hz); 13C NMR (50 MHz, CDCl3) d 153.9, 
153.4, 134.4, 132.4, 129.5, 129.4, 128.5, 127.5, 125.0, 
121.9, 74.5, 61.4; IR (KBr) νmax / cm-1 3055, 1905, 1485, 
1482, 1060; LRMS m/z (%) 446 (100.0), 319 (8.7), 192 
(10.0).
2-Butyl-3,7-diiodobenzofuran (5b)
Yield: 75 mg (71%); orange 
oil; 1H NMR (200 MHz, CDCl3) 
d 7.63 (dd, 1H, J 7.7, 1.1 Hz), 7.27 
(dd, 1H, J 7.8, 1.1 Hz), 7.01 (t, 1H, 
J 7.7 Hz), 2.89 (t, 2H, J 7.5 Hz), 
1.83-1.68 (m, 2H), 1.47-1.25 (m, 
2H), 0.96 (t, 3H, J 7.3 Hz); 13C NMR (50 MHz, CDCl3) 
d 159.8, 154.3, 133.4, 131.0, 124.7, 120.9, 74.4, 63.0, 29.9, 
27.7, 22.2, 13.8; IR (ATR) νmax / cm-1 2891, 2893, 2916, 
2918, 2920, 3045, 1164; LRMS m/z (%) 426 (100.0), 383 
(31.1), 257 (17.4); HRMS (EI-TOF MS) calculated for 
[C12H12I2O]+: 425.8978; found: 425.8986.
5-Chloro-3,7-diiodo-2-phenylbenzofuran (5c)
Yield: 68 mg (57%); 
o f f - w h i t e  s o l i d ;  m . p . 
125-126  °C;  1H  NMR 
( 2 0 0  M H z ,  C D C l 3 ) 
d 8.20-8.15 (m, 2H), 7.67 
(d, 1H, J 2.0 Hz), 7.56-7.45 
(m, 3H), 7.38 (d, 1H, J 2.0 Hz); 13C NMR (50 MHz, 
CDCl3) d 154.9, 152.8, 133.7, 133.1, 129.9, 129.0, 128.6, 
127.6, 121.6, 74.6, 60.3; IR (KBr) νmax / cm-1 3064, 1483, 
1225, 1058; LRMS m/z (%) 480 (100.0), 353 (16.0), 226 
(10.6); HRMS (EI-TOF MS) calculated for [C14H7ClI2O]+: 
479.8275; found: 479.8280.
2-Butyl-5-chloro-3,7-diiodobenzofuran (5d)
Yield: 53 mg (46%); 
o f f - w h i t e  s o l i d ;  m . p . 
9 5 - 9 6  ° C ;  1 H  N M R 
(200 MHz, CDCl3) d 7.59 
(d, 1H, J 2.0 Hz), 7.25 (d, 
1H, J 2.0 Hz), 2.87 (t, 2H, 
J 7.5 Hz), 1.78-1.70 (m, 2H), 1.50-1.32 (m, 2H), 0.96 (t, 
3H, J 7.3 Hz); 13C NMR (50 MHz, CDCl3) d 161.4, 153.1, 
132.6, 131.7, 129.4, 120.6, 74.5, 62.2, 29.7, 27.7, 22.2, 
13.7; IR (KBr) νmax / cm-1 3100, 2958, 2945, 1436, 1157; 
LRMS m/z (%) 460 (100.0), 417 (62.3), 291 (25.8); HRMS 
(EI-TOF MS) calculated for [C12H11ClI2O]+: 459.8588; 
found: 459.8599.
3,7-Diiodo-5-methyl-2-phenylbenzofuran (5e)
Yield: 114 mg (99%); off-white solid; m.p. 120-121 °C; 
1H NMR (200 MHz, CDCl3) d 8.22 (dd, 2H, J 8.1, 1.6 Hz), 
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7.54-7.45 (m, 4H), 7.17 (d, 
1H, J 0.6 Hz), 2.45 (s, 3H); 
13C NMR (50 MHz, CDCl3) 
d 153.5, 152.5, 135.4, 135.1, 
132.2, 129.6, 129.4, 128.5, 
127.5, 121.9, 74.0, 61.1, 20.9; IR (KBr) νmax / cm-1 3014, 
3018, 2910, 2842, 1236, 1064; LRMS m/z (%) 460 (100.0), 
333 (11.2), 207 (5.8); HRMS (EI-TOF MS) calculated for 
[C15H10I2O]+: 459.8821; found: 459.8825.
2-Butyl-3,7-diiodo-5-methylbenzofuran (5f)
Yield: 82.5 mg (75%); 
o r a n g e  o i l ;  1H  N M R 
(200 MHz, CDCl3) d 7.47 
(d, 1H, J 0.9 Hz), 7.05 (d, 
1H, J 0.6 Hz), 2.87 (t, 2H, 
J 7.5 Hz), 2.41 (s, 3H), 
1.81-1.66 (m, 2H), 1.47-1.35 (m, 2H), 0.96 (t, 3H, 
J 7.2 Hz); 13C NMR (50 MHz, CDCl3) d 159.9, 152.8, 
134.7, 134.3, 130.9, 120.9, 73.9, 62.7, 29.9, 27.7, 22.2, 
20.8, 13.7; IR (ATR) νmax / cm-1 3002, 2925, 2921, 1518, 
1135; LRMS m/z (%) 440 (100.0), 397 (26.6), 271 (11.1); 
HRMS (EI-TOF MS) calculated for [C13H14I2O]+: 439.9134; 
found: 439.9140.
3,7-Diiodo-2-(4-methoxyphenyl)benzofuran (5g)
Yield: 118 mg (99%); 
off-white  sol id;  m.p. 
135-137 °C; 1H NMR 
( 2 0 0  M H z ,  C D C l 3) 
d 8.18-8.13 (m, 2H), 7.68 
(dd, 1H, J 7.7, 1.1 Hz), 
7.37 (dd, 1H, J 7.8, 1.1 Hz), 7.1-7.0 (m, 3H), 3.89 (s, 3H); 
13C NMR (50 MHz, CDCl3) d 160.6, 153.8, 153.7, 133.9, 
132.5, 129.2, 125.0, 122.0, 121.6, 114.0, 74.40, 59.6, 55.4; 
IR (KBr) νmax / cm-1 3025, 3010, 2980, 2850, 1250, 1120; 
LRMS m/z (%) 476 (100.0), 397 (26.6), 271 (11.1); HRMS 
(EI-TOF MS) calculated for [C15H10I2O2]+: 475.8770; 
found: 475.8775.
2-(Cyclopentylmethyl)-3,7-diiodobenzofuran (5h)
Yield: 78 mg (69%); orange 
oil; 1H NMR (200 MHz, CDCl3) 
d 7.63 (dd, 1H, J 7.7 0.9 Hz), 7.27 
(d, 1H, J 7.7 Hz), 7.01 (t, 1H, 
J 7.7 Hz) 2.88 (d, 2H, J 7.4 Hz), 
2.41-2.33 (m, 1H), 1.82-1.76 (m, 
2H), 1.71-1.66 (m, 2H), 1.59-1.53 (m, 2H), 1.35-1.30 (m, 
2H); 13C NMR (50 MHz, CDCl3) d 159.7, 154.4, 133.4, 
131.0, 124.7, 120.9, 74.4, 63.4, 39.1, 33.6, 32.4, 24.9; IR 
(ATR) νmax / cm-1 2993, 2920, 2922, 3020, 1591, 1435, 
1220; LRMS m/z (%) 452 (100.0), 384 (74.1), 257 (58.7); 
HRMS (EI-TOF MS) calculated for [C14H14I2O]+: 451.9134; 
found: 451.9145.
5-Chloro-2-(cyclopentylmethyl)-3,7-diiodobenzofuran (5i)
Yield: 54.7 mg (45%); 
o r a n g e  o i l ;  1H  N M R 
(200 MHz, CDCl3) d 7.60 
(d, 1H, J 2.0 Hz), 7.26 (d, 
1H, J 2.0 Hz), 2.87 (d, 2H, 
J 7.4 Hz), 2.39-2.32 (m, 1H), 
1.83-1.78 (m, 2H), 1.71-1.67 (m, 2H), 1.60-1.55 (m, 2H), 
1.34-1.29 (m, 2H); 13C NMR (50 MHz, CDCl3) d 161.4, 
153.3, 132.7, 131.8, 129.5, 120.8, 74.5, 62.6, 39.1, 33.7, 
32.4, 24.9. IR (ATR) νmax / cm-1 3090, 2963, 2951, 1495, 
1101; LRMS m/z (%) 486 (100.0), 360 (74.1), 233 (38.7); 
HRMS (EI-TOF MS) calculated for [C14H13ClI2O]+: 
485.8744; found: 485.8755.
Supplementary Information
Supplementary data (1H and 13C NMR spectra) are 
available free of charge at http://jbcs.sbq.org.br as a PDF file.
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